AtriCure, Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
ATRC
Clean balance sheet with low leverage (0.2× debt-to-equity).
⚠ currently unprofitable (-2% margin).
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $46.75 (+61.1%)
8 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
ATRC
UNH
—
Trailing P/E
27.9×
78.5×
Forward P/E
17.8×
-2.1%
Profit Margin
2.7%
75.0%
Gross Margin
18.8%
-2.4%
ROE
12.2%
13.1%
Revenue Growth
2.0%
—
Earnings Growth
0.7%
1.43
Beta
0.41
—
Price / Book
—
$1.5B
Market Cap
$334.9B
$27 – $43
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →